NEW YORK (Reuters Health) – Patients on beta-blockers who undergo surgery are nearly twice as likely to experience adverse events in the following months if beta-blockers are discontinued,…
NEW YORK (Reuters Health) – Fenofibrate is safe to use in patients with type 2 diabetes and moderate renal impairment, researchers conclude in a report online December 30…
NEW YORK (Reuters Health) – Based on the 2010 American Diabetes Association’s definition of prediabetes, the condition is present in over a third of psychiatric inpatients treated with…
NEW YORK (Reuters Health) – Data released online today in the Journal of the American Medical Association challenge current guidelines for maintaining potassium levels immediately after a heart…
NEW YORK (Reuters Health) – While first-void urine specimens have been used traditionally to test for Chlamydia trachomatis, newer DNA detection methods produce reliable results using midstream specimens,…
NEW YORK (Reuters Health) – For patients with atrial fibrillation (AF) on long-term warfarin therapy, an interruption in treatment more than doubles the risk of death or a…
NEW YORK (Reuters Health) – Cervical intraepithelial neoplasia grade 1 (CIN 1) found on biopsy provides no information on the risk of progression to CIN 3 beyond that…
NEW YORK (Reuters Health) – The effects of an H1 receptor antagonist in reducing allergen-induced nasal symptoms appear to be enhanced with the addition of an H3 receptor…
NEW YORK (Reuters Health) – When a child has a Staphylococcus aureus skin abscess, decolonizing all household members rather than just the individual patient leads to a lower…
NEW YORK (Reuters Health) – Patients requiring chronic nonsteroidal anti-inflammatory drug (NSAID) treatment develop fewer gastric or duodenal ulcers if they take ibuprofen with high-dose famotidine in a…